Minakshi Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 25 Year, 11 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 0.90 M
About Minakshi Laboratories
Minakshi Laboratories Private Limited. (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2000 and has a history of 25 years. Its registered office is in New Delhi, Delhi.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.90 M.
Shakuntla Arora, Ritika, and Shubham Arora serve as directors at the Company.
Company Details
- LocationNew Delhi, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239DL2000PTC103378
- Company No.
103378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2000
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Minakshi Laboratories Private Limited. offer?
Minakshi Laboratories Private Limited. offers a wide range of products and services, including Women Care, Women Care Supplements, Health Conditions, Kidney Care, Liver Care.
Who are the key members and board of directors at Minakshi Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakuntla Arora  | Director | 20-Jan-2000 | Current |
| Ritika | Director | 13-May-2020 | Current |
| Shubham Arora | Director | 13-May-2020 | Current |
Financial Performance of Minakshi Laboratories.
Enhance accessibility to Minakshi Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Minakshi Laboratories?
Unlock access to Minakshi Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.90 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2001 | Punjab National Bank | ₹0.90 M | Open |
How Many Employees Work at Minakshi Laboratories?
Unlock and access historical data on people associated with Minakshi Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Minakshi Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Minakshi Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
